A study that analyzed MALAT1 expression in prostate cancer patients whose biopsies came back positive and those whose did not found the disease, this lncRNA was shown to be considerably greater in biopsy-positive samples (Wang et al., 2014). Here, MALAT1 is linked to prostate carcinoma.